Camber Capital Management’s Endologix Inc ELGX Stock Holding History

Camber Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-930,001	Closed	-$6.15M	–	37
2019 Q1	$6.15M	Buy	930,001 +1	+0%	+$7	0.31%	27
2018 Q4	$6.66M	Hold	930,000	–	–	0.32%	34
2018 Q3	$17.8M	Hold	930,000	–	–	0.76%	24
2018 Q2	$52.6M	Hold	930,000	–	–	2.03%	24
2018 Q1	$39.3M	Buy	930,000 +130,000	+16%	+$5.58M	1.93%	22
2017 Q4	$42.8M	Hold	800,000	–	–	2.09%	18
2017 Q3	$35.7M	Buy	800,000 +50,000	+7%	+$2.28M	2.26%	18
2017 Q2	$36.5M	Buy	750,000 +150,000	+25%	+$8.83M	1.77%	18
2017 Q1	$43.4M	Buy	600,000 +236,500	+65%	+$15.6M	1.76%	20
2016 Q4	$20.8M	Buy	363,500 +263,500	+264%	+$24.1M	1.08%	26
2016 Q3	$12.8M	Sell	100,000 -200,000	-67%	-$25.6M	0.56%	29
2016 Q2	$37.4M	Sell	300,000 -86,450	-22%	-$9.94M	1.81%	26
2016 Q1	$32.3M	Buy	+386,450	New	+$31.9M	1.89%	26

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Camber Capital Management's ELGX Position: Q2 2019 in Review

Camber Capital Management sold out of Endologix Inc (ELGX) in Q2 2019, closing a stake of 930,001 shares — an estimated $6.15M sold.

Camber Capital Management first reported a position in ELGX in Q1 2016 and held it in 13 quarters. The position peaked at $52.6M in Q2 2018. 75 funds tracked by Wall St. Rank hold ELGX as of Q2 2019.

Camber Capital Management reported no remaining Endologix Inc position as of Q2 2019 after selling out during the quarter.
Camber Capital Management sold 930,001 Endologix Inc shares in Q2 2019, an estimated $6.15M.
Camber Capital Management first reported a position in Endologix Inc in Q1 2016 and held it in 13 quarters.
Camber Capital Management's Endologix Inc position peaked at $52.6M in Q2 2018.
75 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2019.

Based on Camber Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.